Protein transduction domain-hA20 fusion protein protects endothelial cells against high glucose-induced injury
Protein transduction domain-hA20 fusion protein protects endothelial cells against high glucose-induced injury
复制标题
蛋白转导结构域-hA20融合蛋白保护内皮细胞免受高糖诱导的损伤
DOI:
10.4238/2012.july.19.9
复制
发表时间:
2012-01-01
影响因子:
0.4
通讯作者:
Zhou, Z. H.
中科院分区:
文献类型:
--
作者:
Hou, C. L.;Huang, Q.;Zhou, Z. H.
We constructed a plasmid containing a protein transduction domain (PTD) and a human A20 (hA20) gene fragment; the fusion protein was obtained by highly expressing this plasmid in the yeast Pichia pastoris GS115. The plasmid was obtained by adding 9xArg and EcoR. recognition sites to the end of the primer, and 6xHis-Tag and Not. recognition sites to its end. After sequencing, the hA20 gene fragment was inserted into plasmid pPIC9k to construct expression vector pPIC9k-PTD-hA20; then, we transfected GS115 with the vector and induced PTD-hA20 protein expression. We purified protein from the yeast fermentation supernatant using a nickel column. Human umbilical vein endothelial cells (HUVECs) were cultured in high glucose medium (30 mM glucose) and in high glucose medium containing different concentrations of protein. Apoptosis of HUVECs was assayed by TUNEL 72 h later. The biological activity tests indicated that the fusion protein not only passed through the cell membrane freely, but also inhibited apoptosis of HUVECs induced by high glucose levels. We conclude that the fusion protein PTD-hA20 has potential for clinical use.